Prenatal diagnosis of skeletal dysplasias using a targeted skeletal gene panel

Prenat Diagn. 2018 Aug;38(9):692-699. doi: 10.1002/pd.5298. Epub 2018 Jul 3.

Abstract

Objective: This study aimed to perform an accurate and precise diagnosis for fetuses with suspected skeletal anomalies based on an incomplete and limited ultrasound phenotype.

Methods: Proband-only targeted skeletal gene panel sequencing was performed on 12 families who had fetuses with suspected skeletal anomalies based on ultrasound evaluations at a mean gestational age of 24 weeks and 3 days. The fetuses all had normal standard genetic testing yield (karyotyping and microarray).

Results: In 10 of 12 fetuses, panel sequencing provided a diagnosis or possible diagnosis with identification of variants in the following genes: FGFR3, COL1A2, IHH, COL2A1, and DYNC2H1. Two cases revealed novel variants in COL2A1 and DYNC2H1.

Conclusions: Our study suggests that targeted skeletal gene panel sequencing is highly sensitive for prenatal diagnosis of fetuses presenting with unexpected ultrasound findings suggestive of a skeletal dysplasia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Diseases, Developmental / diagnosis*
  • Bone Diseases, Developmental / embryology
  • Bone Diseases, Developmental / genetics*
  • Collagen Type II / genetics
  • Cytoplasmic Dyneins / genetics
  • DNA / analysis
  • Female
  • Fetus
  • Genetic Testing / methods*
  • Genotype
  • Gestational Age
  • Humans
  • Phenotype
  • Pregnancy
  • Prenatal Diagnosis / methods*
  • Protein Isoforms / genetics
  • Sensitivity and Specificity
  • Sequence Analysis, DNA
  • Ultrasonography, Prenatal*

Substances

  • COL2A1 protein, human
  • Collagen Type II
  • DYNC2H1 protein, human
  • Protein Isoforms
  • DNA
  • Cytoplasmic Dyneins